Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the Japan Cancer Immunotherapy market. It also provides a detailed overview of the market of different regions across Hokkaido, Tohoku, Kanto, Chubu, Kinki, Chugoku, Shikoku, Kyushu. The report deep analyzes type and application in Japan Cancer Immunotherapy market. Detailed analysis of key players, along with key growth strategies adopted by Cancer Immunotherapy industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Celldex Therapeutics
Atara Biotherapeutics
Juno Therapeutics
NextCure
ZIOPHARM Oncology
Jacobio
NewLink Genetics
Cellectis
Kite Pharma
Incyte Corporation
Bluebird Bio
By Type:
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
By End-User:
Hospitals
ASCs
Cancer Research Centers
Clinics
By Region:
-
Hokkaido
-
Tohoku
-
Kanto
-
Chubu
-
Kinki
-
Chugoku
-
Shikoku
-
Kyushu
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Cancer Immunotherapy Market
-
1.3 Market Segment by Type
1.3.1 Japan Cancer Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026
1.3.2 Japan Cancer Immunotherapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2014 to 2026
1.3.3 Japan Cancer Immunotherapy Market Size and Growth Rate of Immune System Modulators from 2014 to 2026
1.3.4 Japan Cancer Immunotherapy Market Size and Growth Rate of Cancer Vaccines from 2014 to 2026
-
1.4 Market Segment by Application
1.4.1 Japan Cancer Immunotherapy Market Size and Growth Rate of Hospitals from 2014 to 2026
1.4.2 Japan Cancer Immunotherapy Market Size and Growth Rate of ASCs from 2014 to 2026
1.4.3 Japan Cancer Immunotherapy Market Size and Growth Rate of Cancer Research Centers from 2014 to 2026
1.4.4 Japan Cancer Immunotherapy Market Size and Growth Rate of Clinics from 2014 to 2026
-
1.5 Market Segment by Regions
-
1.5.1 Hokkaido Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.2 Tohoku Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.3 Kanto Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.4 Chubu Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.5 Kinki Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.6 Chugoku Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.7 Shikoku Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
1.5.8 Kyushu Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
3 Segmentation of Cancer Immunotherapy Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Cancer Immunotherapy by Major Types
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
3.4.2 Market Size and Growth Rate of Immune Checkpoint Inhibitors
3.4.3 Market Size and Growth Rate of Immune System Modulators
3.4.4 Market Size and Growth Rate of Cancer Vaccines
4 Segmentation of Cancer Immunotherapy Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Cancer Immunotherapy by Major End-Users
4.4.1 Market Size and Growth Rate of Cancer Immunotherapy in Hospitals
4.4.2 Market Size and Growth Rate of Cancer Immunotherapy in ASCs
4.4.3 Market Size and Growth Rate of Cancer Immunotherapy in Cancer Research Centers
4.4.4 Market Size and Growth Rate of Cancer Immunotherapy in Clinics
5 Market Analysis by Regions
-
5.1 Japan Cancer Immunotherapy Production Analysis by Regions
-
5.2 Japan Cancer Immunotherapy Consumption Analysis by Regions
6 Hokkaido Cancer Immunotherapy Landscape Analysis
-
6.1 Hokkaido Cancer Immunotherapy Landscape Analysis by Major Types
-
6.2 Hokkaido Cancer Immunotherapy Landscape Analysis by Major End-Users
7 Tohoku Cancer Immunotherapy Landscape Analysis
-
7.1 Tohoku Cancer Immunotherapy Landscape Analysis by Major Types
-
7.2 Tohoku Cancer Immunotherapy Landscape Analysis by Major End-Users
8 Kanto Cancer Immunotherapy Landscape Analysis
-
8.1 Kanto Cancer Immunotherapy Landscape Analysis by Major Types
-
8.2 Kanto Cancer Immunotherapy Landscape Analysis by Major End-Users
9 Chubu Cancer Immunotherapy Landscape Analysis
-
9.1 Chubu Cancer Immunotherapy Landscape Analysis by Major Types
-
9.2 Chubu Cancer Immunotherapy Landscape Analysis by Major End-Users
10 Kinki Cancer Immunotherapy Landscape Analysis
-
10.1 Kinki Cancer Immunotherapy Landscape Analysis by Major Types
-
10.2 Kinki Cancer Immunotherapy Landscape Analysis by Major End-Users
11 Chugoku Cancer Immunotherapy Landscape Analysis
-
11.1 Chugoku Cancer Immunotherapy Landscape Analysis by Major Types
-
11.2 Chugoku Cancer Immunotherapy Landscape Analysis by Major End-Users
12 Shikoku Cancer Immunotherapy Landscape Analysis
-
12.1 Shikoku Cancer Immunotherapy Landscape Analysis by Major Types
-
12.2 Shikoku Cancer Immunotherapy Landscape Analysis by Major End-Users
13 Kyushu Cancer Immunotherapy Landscape Analysis
-
13.1 Kyushu Cancer Immunotherapy Landscape Analysis by Major Types
-
13.2 Kyushu Cancer Immunotherapy Landscape Analysis by Major End-Users
14 Major Players Profiles
14.1 Celldex Therapeutics
14.1.1 Celldex Therapeutics Company Profile and Recent Development
14.1.2 Market Performance
14.1.3 Product and Service Introduction
14.2 Atara Biotherapeutics
14.2.1 Atara Biotherapeutics Company Profile and Recent Development
14.2.2 Market Performance
14.2.3 Product and Service Introduction
14.3 Juno Therapeutics
14.3.1 Juno Therapeutics Company Profile and Recent Development
14.3.2 Market Performance
14.3.3 Product and Service Introduction
14.4 NextCure
14.4.1 NextCure Company Profile and Recent Development
14.4.2 Market Performance
14.4.3 Product and Service Introduction
14.5 ZIOPHARM Oncology
14.5.1 ZIOPHARM Oncology Company Profile and Recent Development
14.5.2 Market Performance
14.5.3 Product and Service Introduction
14.6 Jacobio
14.6.1 Jacobio Company Profile and Recent Development
14.6.2 Market Performance
14.6.3 Product and Service Introduction
14.7 NewLink Genetics
14.7.1 NewLink Genetics Company Profile and Recent Development
14.7.2 Market Performance
14.7.3 Product and Service Introduction
14.8 Cellectis
14.8.1 Cellectis Company Profile and Recent Development
14.8.2 Market Performance
14.8.3 Product and Service Introduction
14.9 Kite Pharma
14.9.1 Kite Pharma Company Profile and Recent Development
14.9.2 Market Performance
14.9.3 Product and Service Introduction
14.10 Incyte Corporation
14.10.1 Incyte Corporation Company Profile and Recent Development
14.10.2 Market Performance
14.10.3 Product and Service Introduction
14.11 Bluebird Bio
14.11.1 Bluebird Bio Company Profile and Recent Development
14.11.2 Market Performance
14.11.3 Product and Service Introduction
The List of Tables and Figures (Totals 81 Figures and 139 Tables)
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Monoclonal Antibodies from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Immune Checkpoint Inhibitors from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Immune System Modulators from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Cancer Vaccines from 2014 to 2026
-
Figure Market Share by Type in 2014
-
Figure Market Share by Type in 2018
-
Figure Market Share by Type in 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of ASCs from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Cancer Research Centers from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Clinics from 2014 to 2026
-
Figure Market Share by End-User in 2014
-
Figure Market Share by End-User in 2018
-
Figure Market Share by End-User in 2026
-
Figure Hokkaido Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Tohoku Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kanto Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chubu Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kinki Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Chugoku Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Shikoku Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Kyushu Cancer Immunotherapy Consumption Market Size and Growth Rate from 2014 to 2026
-
Figure Development Trends and Industry Dynamics of Cancer Immunotherapy Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2018
-
Figure Market Share of TOP 5 Players in 2018
-
Figure Market Share of TOP 6 Players from 2014 to 2019
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Table Specifications of Different Types of Cancer Immunotherapy
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Cancer Immunotherapy by Different Types from 2014 to 2026
-
Table Consumption Share of Cancer Immunotherapy by Different Types from 2014 to 2026
Figure Market Size and Growth Rate of Monoclonal Antibodies
Figure Market Size and Growth Rate of Immune Checkpoint Inhibitors
Figure Market Size and Growth Rate of Immune System Modulators
Figure Market Size and Growth Rate of Cancer Vaccines
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Table Consumption of Cancer Immunotherapy by Different End-Users from 2014 to 2026
-
Table Consumption Share of Cancer Immunotherapy by Different End-Users from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Hospitals from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of ASCs from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Cancer Research Centers from 2014 to 2026
Figure Japan Cancer Immunotherapy Market Size and Growth Rate of Clinics from 2014 to 2026
-
Table Japan Cancer Immunotherapy Production by Regions
-
Table Japan Cancer Immunotherapy Production Share by Regions
-
Figure Japan Cancer Immunotherapy Production Share by Regions in 2014
-
Figure Japan Cancer Immunotherapy Production Share by Regions in 2018
-
Figure Japan Cancer Immunotherapy Production Share by Regions in 2026
-
Table Japan Cancer Immunotherapy Consumption by Regions
-
Table Japan Cancer Immunotherapy Consumption Share by Regions
-
Figure Japan Cancer Immunotherapy Consumption Share by Regions in 2014
-
Figure Japan Cancer Immunotherapy Consumption Share by Regions in 2018
-
Figure Japan Cancer Immunotherapy Consumption Share by Regions in 2026
-
Table Hokkaido Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Hokkaido Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Hokkaido Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Hokkaido Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Hokkaido Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Hokkaido Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Hokkaido Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Hokkaido Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Hokkaido Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Hokkaido Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Tohoku Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Tohoku Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Tohoku Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Tohoku Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Tohoku Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Tohoku Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Tohoku Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Tohoku Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Tohoku Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Tohoku Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Kanto Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Kanto Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Kanto Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Kanto Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Kanto Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Kanto Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Kanto Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kanto Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Kanto Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Kanto Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Chubu Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Chubu Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Chubu Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Chubu Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Chubu Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Chubu Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Chubu Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chubu Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Chubu Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Chubu Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Kinki Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Kinki Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Kinki Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Kinki Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Kinki Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Kinki Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Kinki Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kinki Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Kinki Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Kinki Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Chugoku Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Chugoku Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Chugoku Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Chugoku Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Chugoku Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Chugoku Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Chugoku Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Chugoku Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Chugoku Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Chugoku Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Shikoku Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Shikoku Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Shikoku Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Shikoku Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Shikoku Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Shikoku Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Shikoku Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Shikoku Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Shikoku Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Shikoku Cancer Immunotherapy Consumption Share by End-Users in 2026
-
Table Kyushu Cancer Immunotherapy Consumption by Types from 2014 to 2026
-
Table Kyushu Cancer Immunotherapy Consumption Share by Types from 2014 to 2026
-
Figure Kyushu Cancer Immunotherapy Consumption Share by Types in 2014
-
Figure Kyushu Cancer Immunotherapy Consumption Share by Types in 2018
-
Figure Kyushu Cancer Immunotherapy Consumption Share by Types in 2026
-
Table Kyushu Cancer Immunotherapy Consumption by End-Users from 2014 to 2026
-
Table Kyushu Cancer Immunotherapy Consumption Share by End-Users from 2014 to 2026
-
Figure Kyushu Cancer Immunotherapy Consumption Share by End-Users in 2014
-
Figure Kyushu Cancer Immunotherapy Consumption Share by End-Users in 2018
-
Figure Kyushu Cancer Immunotherapy Consumption Share by End-Users in 2026
Table Company Profile and Development Status of Celldex Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celldex Therapeutics
Figure Sales and Growth Rate Analysis of Celldex Therapeutics
Figure Revenue and Market Share Analysis of Celldex Therapeutics
Table Product and Service Introduction of Celldex Therapeutics
Table Company Profile and Development Status of Atara Biotherapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Atara Biotherapeutics
Figure Sales and Growth Rate Analysis of Atara Biotherapeutics
Figure Revenue and Market Share Analysis of Atara Biotherapeutics
Table Product and Service Introduction of Atara Biotherapeutics
Table Company Profile and Development Status of Juno Therapeutics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Juno Therapeutics
Figure Sales and Growth Rate Analysis of Juno Therapeutics
Figure Revenue and Market Share Analysis of Juno Therapeutics
Table Product and Service Introduction of Juno Therapeutics
Table Company Profile and Development Status of NextCure
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NextCure
Figure Sales and Growth Rate Analysis of NextCure
Figure Revenue and Market Share Analysis of NextCure
Table Product and Service Introduction of NextCure
Table Company Profile and Development Status of ZIOPHARM Oncology
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ZIOPHARM Oncology
Figure Sales and Growth Rate Analysis of ZIOPHARM Oncology
Figure Revenue and Market Share Analysis of ZIOPHARM Oncology
Table Product and Service Introduction of ZIOPHARM Oncology
Table Company Profile and Development Status of Jacobio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jacobio
Figure Sales and Growth Rate Analysis of Jacobio
Figure Revenue and Market Share Analysis of Jacobio
Table Product and Service Introduction of Jacobio
Table Company Profile and Development Status of NewLink Genetics
Table Sales, Revenue, Sales Price and Gross Margin Analysis of NewLink Genetics
Figure Sales and Growth Rate Analysis of NewLink Genetics
Figure Revenue and Market Share Analysis of NewLink Genetics
Table Product and Service Introduction of NewLink Genetics
Table Company Profile and Development Status of Cellectis
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cellectis
Figure Sales and Growth Rate Analysis of Cellectis
Figure Revenue and Market Share Analysis of Cellectis
Table Product and Service Introduction of Cellectis
Table Company Profile and Development Status of Kite Pharma
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kite Pharma
Figure Sales and Growth Rate Analysis of Kite Pharma
Figure Revenue and Market Share Analysis of Kite Pharma
Table Product and Service Introduction of Kite Pharma
Table Company Profile and Development Status of Incyte Corporation
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Incyte Corporation
Figure Sales and Growth Rate Analysis of Incyte Corporation
Figure Revenue and Market Share Analysis of Incyte Corporation
Table Product and Service Introduction of Incyte Corporation
Table Company Profile and Development Status of Bluebird Bio
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bluebird Bio
Figure Sales and Growth Rate Analysis of Bluebird Bio
Figure Revenue and Market Share Analysis of Bluebird Bio
Table Product and Service Introduction of Bluebird Bio
-
